Clinical trial
Efficacy and Safety of AJU-C52 in Essential Hypertension Patients
NCT06416865
Study timeline
Study start (actual)2022-10-18Date precision: day
Registry last updated2026-09-21
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Essential Hypertensionunresolved
Interventions
C52R1L, C52R1MDRUG
Sponsors & collaborators
AJU Pharm Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06416865 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.